Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A, Fanunza E, Salata C, Morwitzer MJ, Distinto S, Zinzula L, Sanna C, Frau A, Daino GL, Quartu M, Taglialatela-Scafati O, Rigano D, Reid S, Mirazimi A, Tramontano E.
Corona A, et al. Among authors: daino gl.
Antiviral Res. 2022 Feb;198:105251. doi: 10.1016/j.antiviral.2022.105251. Epub 2022 Jan 20.
Antiviral Res. 2022.
PMID: 35066016